Literature DB >> 24976589

Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells.

Haifa Rahabi-Layachi1, Roger Ourouda2, Agnes Boullier1,3,4, Ziad A Massy1,5, Carole Amant2,3.   

Abstract

Inorganic phosphate (Pi) is an essential nutrient to all living organisms. Nevertheless, hyperphosphatemia is now recognized as a risk factor for cardiovascular events and mortality in chronic kidney disease (CKD) patients. To our knowledge, the mechanisms by which elevated Pi alters smooth muscle cell proliferation have been poorly addressed. Therefore, in this study, we investigated the effects of Pi on cell cycle regulation and apoptosis in human aortic smooth muscle cells (HAoSMC). HAoSMC were treated with physiologic (1 mM) or high (2 and 3 mM) Pi concentrations. We showed that Pi not only decreased significantly cell viability (P < 0.001) but also induced apoptosis of HAoSMC. Moreover, Pi treatment blocked G1/S cell cycle progression by increasing cell number in G0/G1 phase up to 82.4 ± 3.4% for 3 mM vs 76.2 ± 3.1% for control (P < 0.01) while decreasing cell number in S phase. Accordingly, this was associated with a decrease protein expression of cyclin E and its associated CDK (CDK2), and phosphorylated retinoblastoma protein. Moreover, we observed an increase of protein expression of cell cycle inhibitors p15, p21, and p27. Interestingly, we also found that induction of cell cycle arrest was partially dependent on phosphate uptake. Our results demonstrated that Pi reduced HAoSMC proliferation by inducing apoptosis and cell cycle arrest. Indeed, we showed for the first time that Pi affected HAoSMC cell cycle by blocking G1/S progression. These findings would be useful for a better understanding of molecular mechanisms involved in vascular complications observed in CKD patients.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24976589     DOI: 10.1002/jcp.24715

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  MicroRNA-21 mediates high phosphate-induced endothelial cell apoptosis.

Authors:  Zhaoyu Li; Szymon Wiernek; Cam Patterson; Huanchen Wang; Guoxian Qi; Xuming Dai
Journal:  Am J Physiol Cell Physiol       Date:  2018-09-26       Impact factor: 4.249

2.  Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons?

Authors:  Luigi Sapio; Silvio Naviglio
Journal:  World J Clin Oncol       Date:  2015-12-10

3.  Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

Authors:  Neda Haghighat; Majid Mohammadshahi; Shokouh Shayanpour; Mohammad Hossein Haghighizadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

Review 4.  The role of phosphate in kidney disease.

Authors:  Marc G Vervloet; Siren Sezer; Ziad A Massy; Lina Johansson; Mario Cozzolino; Denis Fouque
Journal:  Nat Rev Nephrol       Date:  2016-11-21       Impact factor: 28.314

Review 5.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Authors:  Carolla El Chamieh; Sophie Liabeuf; Ziad Massy
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

Review 6.  The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.

Authors:  Lucie Hénaut; Aurélien Mary; Jean-Marc Chillon; Saïd Kamel; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2018-05-29       Impact factor: 4.546

Review 7.  Phosphate intake, hyperphosphatemia, and kidney function.

Authors:  Isabel Rubio-Aliaga; Reto Krapf
Journal:  Pflugers Arch       Date:  2022-05-05       Impact factor: 4.458

Review 8.  Inflammation and Premature Ageing in Chronic Kidney Disease.

Authors:  Thomas Ebert; Sven-Christian Pawelzik; Anna Witasp; Samsul Arefin; Sam Hobson; Karolina Kublickiene; Paul G Shiels; Magnus Bäck; Peter Stenvinkel
Journal:  Toxins (Basel)       Date:  2020-04-04       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.